1. Cokkinos, D. V., and Pantos, C. (2011) Type 1 diabetes impairs compensatory response after myocardial infarction; role of tissue hypothyroidism and effects of thyroid hormone administration, Bull. Acad. Natl. Med., 195, 151-164.
2. Perlman, A. S., Chevalier, J. M., Wilkinson, P., Liu, H., Parker, T., et al. (2015) Serum inflammatory and immune mediators are elevated in early stage diabetic nephropathy, Ann. Clin. Lab. Sci., 45, 256-263.
3. Wang, S., Du, S., Wu, Q., Hu, J., and Li, T. (2015) Decorin prevents retinal pigment epithelial barrier breakdown under diabetic conditions by suppressing p38 MAPK activation, Invest. Ophthalmol. Vis. Sci., 56, 2971-2979,
https://doi.org/10.1167/iovs.14-15874.
4. King, H., Aubert, R. E., and Herman, W. H. (1998) Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections, Diabetes Care, 21, 1414-1431,
https://doi.org/10.2337/diacare.21.9.1414.
5. Shapiro, A. M., Lakey, J. R., Ryan, E. A., Korbutt, G. S., Toth, E., et al. (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using glucocorticoid-free immunosuppressive regimen, N. Engl. J. Med., 343, 230-238,
https://doi.org/10.1056/NEJM200007273430401.